<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00220792</url>
  </required_header>
  <id_info>
    <org_study_id>CA61309</org_study_id>
    <nct_id>NCT00220792</nct_id>
  </id_info>
  <brief_title>Group Therapy for Primary Breast Cancer</brief_title>
  <official_title>A Multicenter Trial of Group Therapy for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Cummings Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether women with primary breast cancer who were
      randomly assigned to receive a brief group therapy would show a greater reduction in mood
      disturbance over time compared to those randomized to the control condition. We also
      hypothesized that women who were highly distressed at baseline would show the greatest
      benefit from participating in a support group, and that therapists with more training and
      experience would be most effective in reducing distress.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer patients often experience significant psychological distress after diagnosis
      and during initial treatment. Group interventions for cancer patients have been shown to
      improve psychological adjustment. The tests of efficacy for these interventions have
      typically taken place in university settings using highly developed models of intervention.
      Our aim was to test our supportive-expressive model in community oncology practices utilizing
      personnel already working with these populations. To conduct this study of group therapy for
      primary breast cancer patients, we developed a brief version of the supportive-expressive
      model (Classen et al., 1993). Our first aim was to test the efficacy of this intervention for
      reducing mood disturbance for women who received the intervention compared to a control
      group. A second aim was to examine who was most likely to benefit from the intervention. A
      third aim was to see if this method could be taught efficiently and effectively to oncology
      nurses and mental health professionals.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 1993</start_date>
  <completion_date>June 1998</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of change in mood disturbance assessed by the Profile of Mood States at baseline, 3 mo, 6 mo, 12 mo, 18 mo and 24 mo.</measure>
  </primary_outcome>
  <enrollment>480</enrollment>
  <condition>Breast Cancer</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Brief supportive-expressive group therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  : 1) diagnosis of primary, biopsy-proven breast cancer, stages I through IIIA; 2)
             diagnosis occurred no more than 12 months prior to recruitment; 3) completion of
             initial surgical treatment; and 4) no detectable disease present.

        Exclusion Criteria:

          -  1) evidence of metastases beyond adjacent lymph nodes, including chest wall
             involvement, bone or viscera; 2) recurrence of the cancer prior to randomization; 3)
             diagnosis of other cancers (except for basal cell or squamous cell carcinoma of the
             skin or in situ cervical cancer) within the past 10 years; 4) any other major medical
             problems likely to limit life expectancy to less than 10 years; 5) a history of major
             psychiatric illness for which the patient was hospitalized or medicated, except for a
             diagnosis of depression or anxiety treated for a period of less than one year; and 6)
             attendance at a cancer support group for more than two months.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Spiegel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Social Work Consultants, Inc</name>
      <address>
        <city>Wichita</city>
        <state>Kansas</state>
        <zip>67202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kalamazoo Community Clinical Oncology Program</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metro-Minnesota CCOP</name>
      <address>
        <city>St. Louis Park</city>
        <state>Minnesota</state>
        <zip>55416</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northern New Jersey CCOP</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital CCOP</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester CCOP</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Syracuse Hem/Onc CCOP</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest CCOP</name>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marshfield Medical Research Foundation</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Milwaukee CCOP</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Han WT, Collie K, Koopman C, Azarow J, Classen C, Morrow GR, Michel B, Brennan-O'Neill E, Spiegel D. Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology. 2005 Apr;14(4):318-30.</citation>
    <PMID>15386762</PMID>
  </reference>
  <reference>
    <citation>Fobair P, Koopman C, DiMiceli S, O'Hanlan K, Butler LD, Classen C, Drooker N, Davids HR, Loulan J, Wallsten D, Spiegel D. Psychosocial intervention for lesbians with primary breast cancer. Psychooncology. 2002 Sep-Oct;11(5):427-38.</citation>
    <PMID>12228876</PMID>
  </reference>
  <reference>
    <citation>Koopman C, Butler LD, Classen C, Giese-Davis J, Morrow GR, Westendorf J, Banerjee T, Spiegel D. Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress. 2002 Aug;15(4):277-87.</citation>
    <PMID>12224799</PMID>
  </reference>
  <reference>
    <citation>Fobair P, O'Hanlan K, Koopman C, Classen C, Dimiceli S, Drooker N, Warner D, Davids H, Loulan J, Wallsten D, Goffinet D, Morrow G, Spiegel D. Comparison of lesbian and heterosexual women's response to newly diagnosed breast cancer. Psychooncology. 2001 Jan-Feb;10(1):40-51.</citation>
    <PMID>11180576</PMID>
  </reference>
  <reference>
    <citation>Spiegel D, Morrow GR, Classen C, Raubertas R, Stott PB, Mudaliar N, Pierce HI, Flynn PJ, Heard L, Riggs G. Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psychooncology. 1999 Nov-Dec;8(6):482-93.</citation>
    <PMID>10607981</PMID>
  </reference>
  <reference>
    <citation>Classen C, Abramson S, Angell K, Atkinson A, Desch C, Vinciguerra VP, Rosenbluth RJ, Kirshner JJ, Hart R, Morrow G, Spiegel D. Effectiveness of a training program for enhancing therapists' understanding of the supportive-expressive treatment model for breast cancer groups. J Psychother Pract Res. 1997 Summer;6(3):211-8.</citation>
    <PMID>9185066</PMID>
  </reference>
  <reference>
    <citation>Spiegel, D., Morrow, G.R., Classen, C., Riggs, G., Stott, P.B., Mudaliar, N., Pierce, H.I., Flynn, P.J., &amp; Heard, L. (1996). Effects of group therapy on women with primary breast cancer. The Breast Journal, 2(1), 104-106.</citation>
  </reference>
  <reference>
    <citation>Azarow, J., Han W.T., Koopman, C., Classen C., Morrow G.R., &amp; Spiegel, D. (2001) Traumatic stress, pain, and self-efficacy are related to breast cancer patientsâ€™ satisfaction with care. Psychosomatic Medicine, 63, 1, 1130</citation>
  </reference>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2005</study_first_submitted>
  <study_first_submitted_qc>September 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>September 15, 2005</last_update_submitted>
  <last_update_submitted_qc>September 15, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2005</last_update_posted>
  <keyword>Primary breast cancer</keyword>
  <keyword>support groups</keyword>
  <keyword>mood disturbance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

